Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchSelect treatment..Select..
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

WHO ends the COVID-19 public health emergency

Burki, T., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(23)00217-5, Jul 2023
https://c19early.org/burki.html
News report on WHO's announcement ending the COVID-19 public health emergency, noting that WHO estimates SARS-CoV-2 has caused at least 20 million deaths.
Burki et al., 31 Jul 2023, peer-reviewed, 1 author.
Abstract: News Sam Falconer, Debut Art/Science Photo Library WHO ends the COVID-19 public health emergency Published Online May 26, 2023 https://doi.org/10.1016/ S2213-2600(23)00217-5 For Tedros’ statement see https://www.who.int/directorgeneral/speeches/detail/whodirector-general-s-openingremarks-at-the-media-briefing--5-may-2023 For more on vaccine estimates see Articles Lancet Infect Dis 2022; 22: 1293–302 For the Strategic Preparedness and Response Plan see https:// www.who.int/publications/i/ item/WHO-WHE-SPP-2023.1 588 On May 5, 2023, WHO DirectorGeneral Tedros Adhanom Ghebreyesus announced that COVID-19 no longer constituted a public health emergency of international concern (PHEIC). “For more than a year, the pandemic has been on a downward trend, with population immunity increasing from vaccination and infection, mortality decreasing and the pressure on health systems easing”, explained Tedros, in remarks to the media. He added that most countries have returned to a life similar to that before the pandemic and the WHO Emergency Committee, on whose advice the PHEIC was declared in January, 2020, was now recommending that the PHEIC be lifted. “It is therefore with great hope that I declare COVID-19 over as a global health emergency”, Tedros concluded. A key criteria for a PHEIC is that an outbreak should be an extraordinary event. The WHO Emergency Committee decided that this criteria was no longer met for COVID-19. “It was the right decision”, commented Amesh Adalja, Senior Scholar at the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA). “In January 2020, this was a novel virus that was threatening the functioning of health-care systems worldwide. We did not have any medical countermeasures and we did not know very much about what we were dealing with. We are in a very different situation today”. Paul Hunter is a Professor in Medicine at the University of East Anglia (Norwich, UK). “The whole issue in the control of COVID-19 has been one of balancing harms against benefits”, he said. “With the exception of vaccination, the interventions that have been used to suppress SARS-CoV-2 on a societal level now mainly do more harm than good. There is no need for the PHEIC”. Two-thirds of the world’s population, including 89% of health workers and 82% of adults older than 60 years, have received at least two doses of the COVID-19 vaccines. A modelling study published in The Lancet Infectious Diseases estimated that the vaccines saved 14·4–19·8 million lives in the first year of rollout. In the week ending May 8, 2023, WHO was notified of 546 435 infections with SARS-CoV-2 and 4266 deaths. Both figures were lower than for any week since March, 2020, although admittedly there is currently far less testing and reporting. “We know that the severity of SARS-CoV-2 decreases the more times you are infected, so for most people this will be an increasingly mild disease”, said Hunter. Discontinuation of the PHEIC is largely of symbolic value. PHEICs capture attention and allow easier raising of funds, but they are not associated with any meaningful power. For US citizens, the expiration of the federal Public Health Emergency for COVID-19 on May 11 was more substantial because it implied looser surveillance and an end to free testing. In his remarks to the media, Tedros urged nations to stay vigilant. “The worst thing any country could do now is to use this news as a reason to let down its guard, to dismantle the systems it has..
DOI record: { "DOI": "10.1016/s2213-2600(23)00217-5", "ISSN": [ "2213-2600" ], "URL": "http://dx.doi.org/10.1016/S2213-2600(23)00217-5", "alternative-id": [ "S2213260023002175" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "WHO ends the COVID-19 public health emergency" }, { "label": "Journal Title", "name": "journaltitle", "value": "The Lancet Respiratory Medicine" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/S2213-2600(23)00217-5" }, { "label": "CrossRef DOI link to the associated document", "name": "associatedlink", "value": "https://doi.org/10.1016/S1473-3099(22)00320-6" }, { "label": "Content Type", "name": "content_type", "value": "simple-article" }, { "label": "Copyright", "name": "copyright", "value": "© 2023 Elsevier Ltd. All rights reserved." } ], "author": [ { "affiliation": [], "family": "Burki", "given": "Talha", "sequence": "first" } ], "container-title": "The Lancet Respiratory Medicine", "container-title-short": "The Lancet Respiratory Medicine", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.fr", "clinicalkey.jp", "clinicalkey.com.au", "clinicalkey.es", "clinicalkey.com", "thelancet.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2023, 5, 26 ] ], "date-time": "2023-05-26T22:35:20Z", "timestamp": 1685140520000 }, "deposited": { "date-parts": [ [ 2023, 7, 5 ] ], "date-time": "2023-07-05T02:17:01Z", "timestamp": 1688523421000 }, "indexed": { "date-parts": [ [ 2025, 8, 12 ] ], "date-time": "2025-08-12T21:45:40Z", "timestamp": 1755035140284 }, "is-referenced-by-count": 70, "issue": "7", "issued": { "date-parts": [ [ 2023, 7 ] ] }, "journal-issue": { "issue": "7", "published-print": { "date-parts": [ [ 2023, 7 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 7, 1 ] ], "date-time": "2023-07-01T00:00:00Z", "timestamp": 1688169600000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2213260023002175?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2213260023002175?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "588", "prefix": "10.1016", "published": { "date-parts": [ [ 2023, 7 ] ] }, "published-print": { "date-parts": [ [ 2023, 7 ] ] }, "publisher": "Elsevier BV", "reference-count": 0, "references-count": 0, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2213260023002175" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "WHO ends the COVID-19 public health emergency", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "11" }
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit